Objective: To determine the olfactory function and/or dysfunction of young adults who are cigarette smokers using a locally validated smell identification test. Design: Cross-sectional study Setting:Tertiary hospital in Metro Manila Patients: The volunteer study group was composed of 60 male and 21 female students and] employees of a tertiary hospital and its affiliated medical school (both in Quezon City). All subjects were young adults within the age range of 20-35 years with a mean age of 27.58 years (+/- 4.33). All the subjects were currently smoking cigarettes with no medical history of recent viral infection, nasal/sinus surgery, nasal/brain tumors, head trauma, radiotherapy, chronic rhinitides in exacerbation ortracheostomy. Olfactory function of each subject was evaluated using the Sto. Tomas Smell Identification Test (ST-SIT) which is a locally-validated test. Results: Majority of the subjects fell within the 24-27 age group with a mean age of 27.58 years (+/- 4.33). Males outnumbered females 74.1 percent as against 25.9 percent. An inverse relation between pack years and ST-SIT score was present indicating that there could be a dose-related effect off cigarette smoking on olfactory function. Among the 81 subjects, 15 (18.5 percent) turned out to be anosmic, 46 (56.7 percent) were hyposmic I and 20 (24.6 percent) had normal olfactory function. A mean ST-SIT score was computed at 81.183 (+/- 12.58), indicating that majority of the subjects had olfactory dysfunction, meaning they were hyposmic. Conclusion: Smoking cigarettes has become part of the lifestyle of a lot of people in spite of its hazards to health. In the present study, a majority of supposedly healthy young adults who currently smoked cigarettes were proven to suffer from olfactory impairment based on the scores of a locally-validated smell identification test. An inverse relation between ST-SIT scores and pack years was also noted which may indicate a dose-related effect of smoking on olfactory function. (Author)
CROSS-SECTIONAL STUDIES SMELL SMOKING OLFACTION DISORDERS ADULT

Objective: To present a case of a benign orbito-maxillary tumor behaving as an invasive, expansive malignancy. Design: Case report Setting: A tertiary care hospital in Metro Manila Patient: A 4 1/2-year-old boy with a seven month history of right orbito-maxillary mass, proptosis and epiphora. Result: A series of biopsies were done before a definite diagnosis was made due to inconsistencies in the histopathologic findings, clinical picture, and the radiologic presentation of the case. After diagnosis, appropriate intervention resulted in a dramatic decrease in the size of the mass. At present, the patient is disease-free and asymptomatic. Conclusion: Histopathologic diagnosis of Inflammatory Pseudotumor is difficult and differentiating it from malignant tumors is often a concern for otolaryngologists and pathologists. In spite of an initial malignant biopsy result, the combination of clinical signs and symptoms and radiologic findings of an infiltrative mass lesion, should not discount the possibility of a benign entity such as Inflammatory Pseudotumor for which treatment is conservative. (Author)
GRANULOMA ; PLASMA CELL GRANULOMA ; PLASMA CELL ; ORBITAL ORBITAL DISEASES

Matrix metalloproteinases (MMPs) are enzymes that can degrade collagen in hybrid layer and reduce the longevity of adhesive restorations. As scientific understanding of the MMPs has advanced, useful strategies focusing on preventing these enzymes' actions by MMP inhibitors have quickly developed in many medical fields. However, in restorative dentistry, it is still not well established. This paper is an overview of the strategies to inhibit MMPs that can achieve a long-lasting material-tooth adhesion. Literature search was performed comprehensively using the electronic databases: PubMed, ScienceDirect and Scopus including articles from May 2007 to December 2019 and the main search terms were “matrix metalloproteinases”, “collagen”, and “dentin” and “hybrid layer”. MMPs typical structure consists of several distinct domains. MMP inhibitors can be divided into 2 main groups: synthetic (syntheticpeptides, non-peptide molecules and compounds, tetracyclines, metallic ions, and others) and natural bioactive inhibitors mainly flavonoids. Selective inhibitors of MMPs promise to be the future for specific targeting of preventing dentin proteolysis. The knowledge about MMPs functionality should be considered to synthesize drugs capable to efficiently and selectively block MMPs chemical routes targeting their inactivation in order to overcome the current limitations of the therapeutic use of MMPs inhibitors, i.e., easy clinical application and long-lasting effect.

Matrix metalloproteinases (MMPs) are enzymes that can degrade collagen in hybrid layer and reduce the longevity of adhesive restorations. As scientific understanding of the MMPs has advanced, useful strategies focusing on preventing these enzymes' actions by MMP inhibitors have quickly developed in many medical fields. However, in restorative dentistry, it is still not well established. This paper is an overview of the strategies to inhibit MMPs that can achieve a long-lasting material-tooth adhesion. Literature search was performed comprehensively using the electronic databases: PubMed, ScienceDirect and Scopus including articles from May 2007 to December 2019 and the main search terms were “matrix metalloproteinases”, “collagen”, and “dentin” and “hybrid layer”. MMPs typical structure consists of several distinct domains. MMP inhibitors can be divided into 2 main groups: synthetic (syntheticpeptides, non-peptide molecules and compounds, tetracyclines, metallic ions, and others) and natural bioactive inhibitors mainly flavonoids. Selective inhibitors of MMPs promise to be the future for specific targeting of preventing dentin proteolysis. The knowledge about MMPs functionality should be considered to synthesize drugs capable to efficiently and selectively block MMPs chemical routes targeting their inactivation in order to overcome the current limitations of the therapeutic use of MMPs inhibitors, i.e., easy clinical application and long-lasting effect.